CervoMed
CRVO
24 hedge funds and large institutions have $4.8M invested in CervoMed in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 4 closing their positions.
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
0% more funds holding
Funds holding: 24 → 24 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.01% less ownership
Funds ownership: 0.13% → 0.12% (-0.01%)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
34% less capital invested
Capital invested by funds: $7.27M → $4.8M (-$2.48M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$30K |
| 2 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
+$8.49K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$7.33K |
| 4 |
LB
Leo Brokerage
Hurst,
Texas
|
+$6.33K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.62K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$209K |
| 2 |
Renaissance Technologies
New York
|
-$139K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$22K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$19.3K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$19K |
CRVO Hedge Fund Activity: Q3 2021 in Review
24 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q3 2021, worth a combined $4.8M — down 34% from $7.27M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new CRVO positions and 4 closed out — a net gain of 1 holder — while 3 added to existing stakes and 4 trimmed.
The largest buyer was Geode Capital Management, adding an estimated $30K. The largest seller was Virtu Financial, exiting entirely with an estimated $209K sold.
- 24 institutional investors held CervoMed (CRVO) as of Q3 2021, unchanged from Q2 2021.
- Funds reported $4.8M of CervoMed stock for Q3 2021, down 34% quarter-over-quarter.
- 5 funds opened new CervoMed positions in Q3 2021 and 4 closed out, a net change of +1 holder.
- The largest CervoMed buyer in Q3 2021 was Geode Capital Management, an estimated $30K added.
- The largest CervoMed seller in Q3 2021 was Virtu Financial, an estimated $209K sold.
Based on aggregated 13F filings for Q3 2021.